{"text": ["Broker", "Darlings", "of", "the", "Dow:", "Pfizer", "Ranks", "As", "a", "Top", "15", "Analyst", "Pick"], "created_at": "2018-10-08 17:06:19"}
{"text": ["Broker", "Darlings", "of", "the", "Dow:", "Pfizer", "Ranks", "As", "a", "Top", "15", "Analyst", "Pick"], "created_at": "2018-10-08 17:06:19"}
{"text": ["Novartis'", "Applications", "for", "MS", "Drug", "Accepted", "by", "FDA", "&", "EMA"], "created_at": "2018-10-08 16:14:42"}
{"text": ["Novartis'", "Applications", "for", "MS", "Drug", "Accepted", "by", "FDA", "&", "EMA"], "created_at": "2018-10-08 16:14:42"}
{"text": ["Novan", "scores", "$11M", "with", "partnership", "with", "Japanese", "pharma"], "created_at": "2018-10-08 16:12:30"}
{"text": ["Novartis&apos;", "Applications", "for", "MS", "Drug", "Accepted", "by", "FDA", "&", "EMA"], "created_at": "2018-10-08 13:40:01"}
{"text": ["Novan", "Expands", "Nitric", "Oxide", "Dermatology", "Business", "Partnership", "with", "Sato", "in", "Japan"], "created_at": "2018-10-08 12:00:00"}
{"text": ["Novartis", "Announces", "FDA", "And", "EMA", "Filing", "Acceptance", "Of", "Siponimod"], "created_at": "2018-10-08 01:31:00"}
{"text": ["Novartis", "Announces", "FDA", "And", "EMA", "Filing", "Acceptance", "Of", "Siponimod"], "created_at": "2018-10-08 01:31:00"}
